John F. Crowley is an American business and social entrepreneur. He is best known as the co-founder of several biotech companies devoted to developing treatments for human genetic diseases. Crowley's involvement with biotech stems from the 1998 diagnosis of two of his children with Pompe disease – a severe and often fatal neuromuscular disorder. In his drive to find a cure for them, he left his post at Bristol-Myers Squibb and became an entrepreneur as the co-founder, president, and CEO of Novazyme Pharmaceuticals, a biotech startup conducting research on a new experimental treatment for Pompe disease (which he credits as ultimately saving his children's lives.)

In 2001, Novazyme merged into Genzyme Corp., the world's third-largest biotech company, and Crowley continued to play a role in the development of a drug for Pompe disease as Senior Vice President of Genzyme Therapeutics. He is presently the President & CEO of Amicus Therapeutics, Inc. Crowley and his family have been profiled in The Wall Street Journal and are the subjects of a book by Pulitzer prize-winning journalist Geeta Anand, entitled The Cure: How a Father Raised $100 Million-And Bucked the Medical Establishment-In a Quest to Save His Children. CBS Films is making a major motion picture about Crowley and his family, starring Harrison Ford, Brendan Fraser and Keri Russell. The film is set for release in April 2010.

Crowley is also a commissioned officer in the US Navy Reserve, assigned to the United States Special Operations Command. He graduated with a BS in Foreign Service from Georgetown University, and earned a JD from the University of Notre Dame Law School and an MBA from Harvard. A Henry Crown Fellow at the Aspen Institute, Crowley was recently named "The Humanitarian of the Year" for 2009 by the Make A Wish Foundation.

P. K. Tandon, Ph.D.
Senior Vice President, Genzyme Corporation, Inc.

Dr. Tandon is the Senior Vice President of Global Biomedical Data Sciences and Informatics. He joined Genzyme in 1997 and is responsible for leading a global group of biostatistics, data management, statistical programming, electronic data submissions and data capture, information systems and medical writing. Prior to Genzyme, Dr. Tandon was a Senior Director at Astra USA and an Assistant Director at Sterling Research Group. Areas of expertise include interim monitoring of the data, sequential designs, phase 4 and health outcomes trials. He has a keen interest in the application of information technology in clinical trials. Dr. Tandon is a part of the Genzyme team leading major efforts in establishing clinical development opportunities in India. Dr. Tandon received his PhD from The Ohio State University and holds an Executive Program diploma from the Sloan School of Management, MIT. Dr. Tandon also serves as an Associate Professor, Department of Biostatistics and Epidemiology, School of Public Health, Boston University.